Radiotherapy is one of the primary interventions used to limit the progress of Hodgkin’s lymphoma (HL). Traditionally, chemotherapy with or without radiotherapy has been used to improve survival in patients. The decision to include radiotherapy in the treatment protocol for HL usually depends on the severity of the cancer at the time of diagnosis. Recently, studies following HL survivors for a longer duration after remission have found an increased occurrence of secondary malignant neoplasms and cardiovascular diseases. Such adverse effects lower the quality of life in surviving patients. Radiotherapeutic intervention in patients with HL should be implemented only after careful examination of patient parameters that necessitate this treatment strategy. Knowledge of risks and benefits of this intervention is helpful for recommending effective treatment plans.
Olive Peart, MS, RT(R)(M), is a SME Writer with Relias. She is an established author, radiographer and educator with years of experience as a radiologic technology program director. She has authored several radiology and mammography related textbooks. She also volunteers with RAD-AID international and served as a program manager with the Asha Jyoti: Women's Healthcare Mobile Outreach Programme, Chandigarh, India and currently serves as RAD-AID's Chief Mammography Technologist for the RAD-AID USA Women's Health Initiative.
Certificates provided by accrediting body (2 Match)
American Society of Radiologic Technologists
Mississippi State Department of Health Bureau of Professional Licensure Medical Radiation Technologists
Course Delivery Method and Format: